STOCK TITAN

Labcorp Holdings Inc - LH STOCK NEWS

Welcome to our dedicated page for Labcorp Holdings news (Ticker: LH), a resource for investors and traders seeking the latest updates and insights on Labcorp Holdings stock.

Labcorp Holdings Inc (LH) delivers essential clinical diagnostics and advanced laboratory solutions that shape modern medical decision-making. This dedicated news hub provides investors and healthcare professionals with timely updates on Labcorp's operational developments, scientific advancements, and strategic initiatives.

Access curated press releases and analysis covering earnings reports, partnership announcements, and innovations in precision oncology diagnostics. Track Labcorp's progress in genomic sequencing technologies and biopharma collaborations through verified updates from primary sources.

The resource consolidates critical information about Labcorp's laboratory network expansions, regulatory milestones, and service enhancements across clinical testing and drug development sectors. Users gain insights into how the company maintains its leadership through scientific rigor and operational scale.

Bookmark this page for streamlined access to Labcorp's evolving role in healthcare innovation, with updates organized for efficient navigation. Return regularly to stay informed about developments impacting diagnostic capabilities and research partnerships in the life sciences sector.

Rhea-AI Summary
Labcorp (NYSE: LH) Announces Collaboration with Geneoscopy Inc. to Expand Access to Colorectal Cancer Screening Test - Geneoscopy Inc. and Labcorp have formed a strategic collaboration to increase patient and provider access to a next-generation colorectal cancer screening test. The test, currently under FDA review, offers at-home collection and high sensitivity for early cancer detection. The collaboration aims to reduce barriers to screening and address health inequities by making the test conveniently available through Labcorp's comprehensive screening programs.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.78%
Tags
none
-
Rhea-AI Summary
Ovia Health by Labcorp (Ovia) announces a first-of-its-kind Fertility and Family Building Benefit, offering comprehensive support for pre-conception, adoption, and surrogacy. The customizable solution aims to remove barriers to care access and provide inclusive support for diverse family-building journeys. The benefit includes the Ovia Walletâ„¢, care navigation, and concierge support, addressing the needs of employers and health plans to improve health outcomes and lower costs, while also promoting greater health equity.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.55%
Tags
none
-
Rhea-AI Summary
Labcorp updates full-year guidance after reporting 6.6% revenue growth in Q3. Advanced hospital and health systems strategy through new agreements. Launches new test for Alzheimer's disease diagnosis.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.16%
Tags
News
Rhea-AI Summary
Labcorp declares cash dividend of $0.72 per share of common stock
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.01%
Tags
dividends
-
Rhea-AI Summary
Labcorp launches blood-based test for Alzheimer's disease detection
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.33%
Tags
none
-
Rhea-AI Summary
Labcorp to acquire Baystate Health's outreach laboratory business and select operating assets
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.23%
Tags
none
Rhea-AI Summary
Labcorp will release its financial results for Q3 2023 on October 26, 2023. Conference call and webcast to discuss the results will be held at 9 a.m. ET. Webcast recording will be available until October 12, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.09%
Tags
-
Rhea-AI Summary
Graves Gilbert collaborates with Circuit Clinical to bring clinical trials to patients in Kentucky, supported by Labcorp. The partnership aims to improve patient outcomes and provide greater access to innovative medical research. Patients may participate in hybrid care options and receive extra care visits without co-pays. This collaboration demonstrates a commitment to diverse and medically underserved communities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.25%
Tags
-
Rhea-AI Summary
Labcorp hosts Investor Day to share growth strategy and value proposition
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.43%
Tags
conferences
Rhea-AI Summary
Labcorp has announced an agreement with Tufts Medicine to acquire the Tufts Medicine outreach laboratory business and select operating assets. This partnership aims to improve access to testing, reduce wait-times for patients, and provide standardized laboratory testing throughout the Tufts Medicine system. The transaction is expected to be finalized in October 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.15%
Tags
partnership acquisition
Labcorp Holdings Inc

NYSE:LH

LH Rankings

LH Stock Data

18.17B
83.32M
0.34%
96.06%
2.21%
Diagnostics & Research
Services-medical Laboratories
Link
United States
BURLINGTON